Filing Details

Accession Number:
0001171843-17-007254
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-11-22 17:01:40
Reporting Period:
2017-11-21
Accepted Time:
2017-11-22 17:01:40
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
3116 Akorn Inc AKRX Pharmaceutical Preparations (2834) 720717400
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1467848 Brian Tambi 1925 West Field Court Suite 300
Lake Forest IL 60045
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2017-11-21 15,100 $33.35 51,075 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. Following the reported transaction, the amount of shares beneficially owned includes 12,426 unvested RSUs and 38,649 shares owned outright.